We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $9.37B
1-Year Est. Return 36.4%
This Fund
S&P 500
This Quarter Est. Return
-2.62%
1 Year Est. Return
+36.4%
3 Year Est. Return
+114.29%
5 Year Est. Return
+137.63%
10 Year Est. Return
+535.77%
AUM
$4.84B
AUM Growth
-$154M
Cap. Flow
+$25M
Cap. Flow %
0.52%
Top 10 Hldgs %
18.29%
Holding
1,493
New
82
Increased
580
Reduced
615
Closed
118

Sector Composition

Rank Sector Weight
1 Technology 18.65%
2 Financials 10.44%
3 Healthcare 9.35%
4 Industrials 8.91%
5 Consumer Discretionary 7.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HIO
1301
Western Asset High Income Opportunity Fund
HIO
$338M
$138K ﹤0.01%
38,013
-495
-1% -$1.88K
TEVA icon
1302
Teva Pharmaceuticals
TEVA
$42.1B
$137K ﹤0.01%
13,415
-4,455
-25% -$41.5K
MWA icon
1303
Mueller Water Products
MWA
$4.07B
$137K ﹤0.01%
10,773
CIM
1304
Chimera Investment
CIM
$980M
$135K ﹤0.01%
8,250
THW
1305
abrdn World Healthcare Fund
THW
$557M
$132K ﹤0.01%
11,233
+1,034
+10% +$13.8K
AMPS
1306
DELISTED
Altus Power
AMPS
$131K ﹤0.01%
25,000
-5,000
-17% -$30.6K
HBAN icon
1307
Huntington Bancshares
HBAN
$35.6B
$129K ﹤0.01%
12,371
-1,130
-8% -$12.7K
BGY icon
1308
BlackRock Enhanced International Dividend Trust
BGY
$533M
$128K ﹤0.01%
25,675
-2,904
-10% -$15.3K
JRI icon
1309
Nuveen Real Asset Income & Growth Fund
JRI
$352M
$120K ﹤0.01%
11,279
+36
+0.3% +$404
RIOT icon
1310
Riot Platforms
RIOT
$7.34B
$119K ﹤0.01%
12,770
+2,500
+24% +$34.4K
NVAX icon
1311
Novavax
NVAX
$1.3B
$118K ﹤0.01%
16,367
-2,750
-14% -$22K
KOPN icon
1312
Kopin
KOPN
$780M
$116K ﹤0.01%
95,000
MSOS icon
1313
AdvisorShares Pure US Cannabis ETF
MSOS
$884M
$114K ﹤0.01%
14,417
-120,924
-89% -$763K
AG icon
1314
First Majestic Silver
AG
$9.29B
$109K ﹤0.01%
21,255
EVV
1315
Eaton Vance Limited Duration Income Fund
EVV
$1.07B
$109K ﹤0.01%
12,061
+161
+1% +$1.5K
ATXS
1316
DELISTED
Astria Therapeutics
ATXS
$108K ﹤0.01%
14,527
WIW
1317
Western Asset Inflation-Linked Opportunities & Income Fund
WIW
$510M
$108K ﹤0.01%
13,100
MQY icon
1318
BlackRock MuniYield Quality Fund
MQY
$815M
$106K ﹤0.01%
+10,365
New +$117K
MIR icon
1319
Mirion Technologies
MIR
$3.75B
$104K ﹤0.01%
13,900
MMU
1320
Western Asset Managed Municipals Fund
MMU
$554M
$101K ﹤0.01%
11,351
+32
+0.3% +$310
FPL
1321
DELISTED
FIRST TRUST NEW OPPORTUNITIES MLP & ENERGY FUND
FPL
$99.7K ﹤0.01%
15,928
-8,409
-35% -$52.9K
MCRB icon
1322
Seres Therapeutics
MCRB
$50.2M
$99K ﹤0.01%
2,079
+138
+7% +$10.5K
EAD
1323
Allspring Income Opportunities Fund
EAD
$378M
$98.2K ﹤0.01%
16,100
-4,000
-20% -$25.3K
CHW
1324
Calamos Global Dynamic Income Fund
CHW
$555M
$97.4K ﹤0.01%
17,584
+150
+0.9% +$894
FSR
1325
DELISTED
Fisker Inc.
FSR
$97.3K ﹤0.01%
15,150

Similar funds

Oppenheimer & Co's Q3 2023 Portfolio in Review

As of Q3 2023, Oppenheimer & Co held 1,493 positions worth $4.84B, down 3.1% from $5B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Oppenheimer & Co's Q3 2023 filing shows 82 new, 580 increased, 615 reduced and 118 closed positions. Its largest new stake was FT Vest US Equity Deep Buffer ETF August: 562,231 shares worth $18.6M. The largest sale was FT Vest US Equity Deep Buffer ETF December, an estimated $15.1M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Financials and Healthcare.

  • Oppenheimer & Co's largest Q3 2023 buy was FT Vest US Equity Deep Buffer ETF August: 562,231 shares worth $18.6M.
  • Oppenheimer & Co added most to ConocoPhillips in Q3 2023, an estimated $4.53M increase.
  • Oppenheimer & Co's biggest Q3 2023 reduction was Equitrans Midstream Corporation Common Stock, cutting an estimated $7.88M.
  • Oppenheimer & Co fully exited FT Vest US Equity Deep Buffer ETF December in Q3 2023, selling an estimated $15.1M.
  • Oppenheimer & Co's ten largest holdings make up 18% of its $4.84B portfolio in Q3 2023.
  • Oppenheimer & Co opened 82 new positions and closed 118 in Q3 2023.
  • Oppenheimer & Co's portfolio value fell 3.1% quarter-over-quarter to $4.84B.

Based on Oppenheimer & Co's 13F filing for Q3 2023, filed 8 Nov 2023.